ArticleJCO oncology advances2024

Disparities in Utilization of Immune Checkpoint Inhibitor Therapy Among Older Patients With Advanced Non-Small Cell Lung Cancer: A SEER-Medicare Analysis.

Danting Yang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.